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INTRODUCTORY PARAGRAPH 129 
Variation in body fat distribution contributes to the metabolic sequelae of obesity. The genetic 130 
determinants of body fat distribution are poorly understood. The goal of this study was to gain 131 
new insights into the underlying genetics of body fat distribution by conducting sample-size 132 
weighted fixed-effects genome-wide association meta-analyses in up to 9,594 women and 133 
8,738 men for six ectopic fat traits in European, African, Hispanic, and Chinese ancestry 134 
populations, with and without sex stratification. In total, 7 new loci were identified in association 135 
with ectopic fat traits (ATXN1, UBE2E2, EBF1, RREB1, GSDMB, GRAMD3 and ENSA; P<5x10-136 
8; FDR<1%). Functional analysis of these genes revealed that loss of function of both ATXN1 137 
and UBE2E2 in primary mouse adipose progenitor cells impaired adipocyte differentiation, 138 
suggesting a physiological role for ATXN1 and UBE2E2 in adipogenesis.  Future studies are 139 
necessary to further explore the mechanisms by which these genes impact adipocyte biology 140 
and how their perturbations contribute to systemic metabolic disease.  141 
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MAIN TEXT 142 
Variation in body fat distribution is associated with cardiometabolic risk, including 143 
diabetes, hypertension and coronary heart disease,1-5 and is at least partially independent of 144 
total adiposity. Adipose tissue can be quantified non-invasively using computed tomography 145 
(CT) and magnetic-resonance imaging (MRI) to measure fat volume and fat attenuation in 146 
different tissue compartments.  We previously demonstrated that both indices, in addition to 147 
relative fat distribution, are important predictors of cardiometabolic risk.6-11 148 
Several lines of evidence suggest a unique genetic component to body fat distribution. 149 
First, indices of body fat distribution are heritable with values ranging from 36-47%, even after 150 
adjustment for body mass index (BMI).12 Second, unique genetic loci exist for body fat 151 
distribution.  For example, we identified a SNP associated with pericardial fat13 that was not 152 
associated with visceral fat,12 BMI or waist-hip-ratio (WHR).14,15 Third, several lipodystrophy 153 
syndromes, characterized by abnormal body fat distribution, are genetically mediated.16 154 
The current study presents a genome-wide association study and meta-analysis of 155 
adipose tissue traits derived from imaging biomarkers (Supplementary Table 1) from 2.6 million 156 
SNPs in up to 9,594 women and 8,738 men of European, African, Hispanic and Chinese 157 
ancestry (see Supplementary Tables 2, 3 and 4) and uses mouse models to characterize 158 
selected loci. 159 
 Subcutaneous and visceral adipose tissue (SAT, VAT) were previously estimated to 160 
have heritabilities of 57% and 36%, respectively12,17 (Supplementary Table 5). To assess the 161 
genetic contribution to variation in fat attenuation traits, which serve as indirect markers of fat 162 
quality (SAT Hounsfield Units [SATHU] and VATHU), heritability (H2) was estimated in 3,312 163 
women and men in the Framingham Heart Study (FHS), and found to be between 29-31% 164 
(P<1x10-15).  To assess the shared genetic contribution between ectopic fat traits, the genetic 165 
correlations were estimated among 3,336 women and men in FHS. Moderate to strong 166 
statistically significant correlations were observed between almost all ectopic fat traits pairs 167 
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(0.35 to 0.67 and -0.74 to -0.35, all P<5x10-4; Supplementary Table 6), suggesting shared loci 168 
between ectopic fat traits. However, not all genes were shared between traits (P<5x10-11 for 169 
non-overlapping correlations for all pairwise comparisons).  The genetic correlations across the 170 
ectopic fat traits are also reflected in the phenotypic correlations (Supplementary Table 7). 171 
In this combined multiethnic sample-size weighted fixed-effects meta-analysis18,19 of up 172 
to 18,332 participants, a total of 11 locus-trait associations (7 novel and 4 known) attained 173 
genome-wide significance (P<5x10-8) out of 27 genomic scans (from analysis of 9 traits and 174 
models in 3 strata – overall, women and men). Of the 7 novel loci, 3 were associated with 175 
volumetric subcutaneous (GSDMB) and visceral fat traits (GRAMD3 and RREB1), 2 were 176 
associated with pericardial fat (ENSA and EBF1), 1 was associated with fat attenuation 177 
(ATXN1), and 1 was associated with relative fat distribution (VAT/SAT ratio [UBE2E2]) (Table 1; 178 
Supplementary Figures 1a-g; with imputation quality in Supplementary Table 8).  Associations 179 
were robust across ancestry-stratified sensitivity analyses (Supplementary Figures 2a-g and 3a-180 
g; Supplementary Table 9).  Manhattan plots and QQ plots for each analysis showed minimal 181 
inflation of association test statistics (Supplementary Figures 4a-g).  The remaining 4 loci 182 
(LYPLAL1, LY86, FTO, TRIB2) attaining genome-wide significance were previously 183 
identified.12,13 184 
 rs2123685, located between the 3’ untranslated regions of ZPBP2 and GSDMB, was 185 
associated with SAT in women only (Pwomen=3.4x10-8, Supplementary Table 10a).  Investigation 186 
of related ectopic traits among women revealed a direction-consistent nominal association with 187 
VAT (P=4.8x10-4).  SNPs at FTO, the canonical-BMI locus, attained genome-wide significance 188 
in association with SAT in the overall sample (P=1.4x10-9). 189 
 The newly identified association at RREB1 with VATadjBMI (rs2842895, P=1.1x10-8) 190 
was observed in the overall sample and both sexes (Supplementary Table 10b).   Examination 191 
of related ectopic traits demonstrated nominal associations with VAT and VAT/SAT ratio adjBMI 192 
(P=4.8x10-5 and P=8.9x10-6 respectively).  The newly identified association of rs10060123 near 193 
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GRAMD3 for VATadjBMI was specific to women (P=4.5x10-8).  This locus was nominally 194 
associated with VAT and VAT/SAT ratio adjBMI in women (Supplementary Table 10c).   195 
 PAT represents distinct ectopic fat deposition around the heart. Two findings in the 196 
overall sample at the ENSA and EBF1 loci (P=2.8x10-9 and 1.0x10-9, respectively, Table 1) have 197 
not been previously associated with ectopic fat, general adiposity or body fat distribution.  198 
Associations at ENSA and EBF1 did not appear to be sex-specific (Supplementary Tables 10d 199 
and 10e).  Further investigation of the ENSA and EBF1 loci showed no associations with SAT, 200 
VAT or VAT/SAT ratio, underscoring their specificity to PAT.  TRIB2 was associated with PAT in 201 
this and our prior meta-analysis (P<5x10-8).13   202 
 Cellular characteristics of fat quality, such as lipid content, vascularity, and adipocyte 203 
size and number, may be important factors influencing metabolic risk,7,10 but direct assessment 204 
is invasive.  Fat attenuation traits, assessed with computed tomography, are correlated with fat 205 
quality characteristics20,21 and thus represent indirect markers of fat quality. ATXN1 was 206 
associated with SATHU among men only (P=1.4x10-8) with no association among women 207 
(P=0.36, Supplementary Table 10f). Examination of related ectopic fat traits indicated similar 208 
direction of association with VATHU, and opposite direction for SAT and VAT (Supplementary 209 
Table 10f) which is consistent with epidemiology findings.7   210 
 The ratio of visceral to subcutaneous fat volumes (VAT/SAT ratio) represents the 211 
propensity to store fat viscerally. UBE2E2 was associated with VAT/SAT ratio (P=3.1x10-10); a 212 
nominal association was also identified with VAT (P=1.4x10-3) but not SAT, suggesting the 213 
finding is mostly driven by the higher relative abundance of VAT. The direction of association in 214 
both sex strata was consistent (Supplementary Table 10g).  Two known body fat distribution 215 
loci, LYPLAL1 and LY86, were also associated with VAT/SAT ratio at genome-wide significance 216 
(Table 1), consistent with our prior analyses.12,22  217 
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Calculation of false discovery rate (FDR) to account for multiple testing across the 27 218 
meta-analyses showed all ectopic fat loci that attained genome-wide significance in each 219 
individual GWAS (P<5x10-8) also attained an FDR<1%.    220 
To examine the association of the 7 newly identified ectopic fat loci with BMI and WHR, 221 
cross-trait evaluations for each lead SNP were performed in the most recent GIANT meta-222 
GWAS, with sample sizes ~10-20 times larger than the current study.14,15  Only 2 out of 14 SNP-223 
trait (BMI or WHR) associations were significant after Bonferroni correction for multiple testing 224 
(P<0.05/14=3.6x10-3; Supplementary Table 10a-g), highlighting the specificity and uniqueness 225 
of the ectopic fat loci.  226 
To evaluate the relationship between the known 97 BMI and 49 WHR loci14,15 and 227 
ectopic fat traits, we examined the association for these loci with fat volume and relative fat 228 
volume traits among the combined multiethnic sample of women and men.   Because the 229 
ectopic fat data may be underpowered to determine statistically significant results, we 230 
hypothesized that the direction of the BMI and WHR findings would be directionally consistent 231 
with abdominal ectopic traits, even if the p-values were not significant (Supplementary Table 232 
11).  Direction consistent SNP-trait associations between SAT and BMI were observed for 87 of 233 
97 loci (Pbinomial=8.9x10-17). When restricted to the 27 loci nominally associated with SAT 234 
(PSAT<0.05), all 27 SNP-SAT associations were directionally consistent with BMI 235 
(Pbinominal=7.5x10-9).  SAT is not an ectopic fat depot and may represent a metabolic sink for 236 
healthier fat storage that is highly correlated with BMI and shares genetic risk factors (as shown 237 
with the enriched number of direction consistent associations), yet also represents a unique 238 
metric of fat distribution with unique genetic influences (as shown with the GSDMB-SAT 239 
association).  No other traits showed directionally consistent associations with the BMI or WHR 240 
(all P>0.05).  These results further underscore how ectopic fat traits are uniquely disparate traits 241 
as compared to BMI and WHR.  242 
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 Ectopic fat depots are associated with cardiometabolic risk and cardiovascular events.8-243 
11  To gain insight into potential mechanisms linking these conditions, we evaluated the 244 
association of the new ectopic fat loci with traits from large-scale genetics consortia.  Of 66 pairs 245 
of lead SNP-trait associations examined, 3 associations (UBE2E2-type 2 diabetes [T2D], EBF1-246 
triglycerides, and EBF1-HDL cholesterol) were statistically significant after Bonferroni correction 247 
for multiple testing (P<0.05/66=8x10-4; Supplementary Table 12).  248 
To examine if any of the new variants overlap with known regulatory regions in adipose 249 
tissue, lead SNPs and variants in linkage disequilibrium (LD) with the lead SNPs (r2>0.8) were 250 
interrogated using ENCODE Consortium data implemented in HaploReg23 and RegulomeDB.24 251 
Except for ATXN1, all other loci contained SNPs in LD with the lead SNP that overlapped with 252 
known regulatory regions in adipose tissue.  For example, the lead UBE2E2 variant 253 
(rs7374732), and other SNPs in LD, overlapped with a known enhancer region in adipose 254 
derived stem cells (Supplementary Table 13).  255 
The list of candidate loci was further prioritized based on visual examination of regional 256 
association plots (Supplementary Figures 1a-g) and identification of 1) a localized association 257 
within a gene body at each locus (RREB1, ATXN1 and UBE2E2), or 2) a localized association 258 
near the gene body concomitant with the lack of other genes within 1Mbp of the lead SNP 259 
(EBF1).  In applying these criteria, four genes were selected for additional functional study.  260 
To test the hypothesis that inter-depot differences in gene expression or their dynamic 261 
regulation during adipocyte development would identify candidates with a higher likelihood of 262 
functional significance, expression of 4 genes (Ebf1, Rreb1 Atxn1, Ube2e2) in murine SAT, 263 
VAT, and PAT depots was assessed by qPCR. Ube2e2 was expressed more highly in the 264 
perigonadal VAT of 6 week-old C57BL/6 mice relative to the SAT (2.1 fold, p<0.05, n=5) or PAT 265 
(2.6 fold, p<0.01, n=5), but no differences were observed for Ebf1, Rreb1 or Atxn1 (Figure 1a). 266 
Differential gene expression of these 4 genes was also assessed in murine diet-induced 267 
obesity.  A 2.1 fold induction of Atxn1 expression in SAT of diet-induced obese mice was 268 
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observed relative to lean controls (p<0.05, n=6).  Significant differences were not observed for 269 
Ebf1, Rreb1, or Ube2e2 in response to the obesogenic stimulus (Figure 1b).  270 
 To explore a potential role for the candidate genes in adipocyte development, we 271 
examined their regulation during ex vivo adipogenic differentiation of progenitor-rich stromal-272 
vascular cell fractions isolated from the subcutaneous and visceral depots of C57BL/6 mice. 273 
Candidate gene expression was measured at regular intervals during adipogenic differentiation. 274 
In progenitors isolated from both VAT and SAT, we observed a significant down-regulation of 275 
Atxn1, Ube2e2, and Ebf1 during adipogenesis (Figure 1c and Supplementary Figure 5).  276 
However, in all three instances the expression returned to near baseline levels by 96h post-277 
adipogenic induction. In contrast, no significant transcriptional regulation of Rreb1 after 278 
adipogenic induction was observed (Supplementary Figure 5).   279 
Both Atxn1 and Ube2Ee2 showed evidence of dynamic regulation of gene expression 280 
during adipogenesis with variable depot-specific expression in the murine models providing 281 
rationale to further explore their functional significance with a genetic loss-of-function assay.  282 
Knock-down of both genes with specific shRNA retroviral constructs during ex vivo 283 
adipogenesis of SAT progenitors impaired the formation of lipid-containing adipocytes relative to 284 
vector control infected cells, whereas only Ube2e2 knock-down impaired adipogenesis in 285 
progenitors isolated from VAT (Figure 1d,e).  286 
 Our findings provide insight into the genetics of body fat distribution.  The scant number 287 
of significant associations observed between the ectopic fat loci and more general measures of 288 
adiposity, such as BMI and WHR,14,15 demonstrates the specificity of the ectopic fat 289 
associations, highlights the utility of precise phenotyping of fat distribution, and suggests 290 
different mechanisms involved in ectopic fat storage compared to more general adiposity 291 
measures.  This specificity was particularly notable for PAT loci, which demonstrate no 292 
associations with SAT, VAT, VAT/SAT ratio, BMI or WHR.  293 
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In addition, few cross-trait associations were observed for ectopic fat loci and other 294 
cardiometabolic traits, which is striking given the epidemiologic associations between ectopic fat 295 
and cardiometabolic risk1-5.  One notable exception is UBE2E2, which is a known T2D locus25,26. 296 
The lead T2D SNP does not appear to be in LD with the lead SNP from our study (r2[rs7374732, 297 
rs7612463]<0.08 across all HapMap2 populations), and therefore likely represents an 298 
independent signal.  The major allele at rs7374732 is associated with both lower VAT/SAT ratio 299 
and lower risk of T2D, suggesting that targeting relative fat distribution may have beneficial 300 
downstream effects.  301 
Functional studies support a physiologic role for UBE2E2 and ATXN1 through regulation 302 
of adipocyte differentiation. ATXN1 encodes a chromatin binding factor involved in the 303 
repression of Notch signaling. It has been implicated in neurologic diseases, including 304 
spinocerebellar ataxia 1, but there are no reported associations between SNPs in ATXN1 and 305 
adiposity-related traits.  In contrast, UBE2E2 is a known T2D GWAS locus,25-27 although the 306 
markers are in low LD with the lead SNP in the present study.  UBE2E2 (3p24.2) encodes the 307 
ubiquitin-conjugating enzyme E2E2, which is expressed in human pancreas, liver, muscle and 308 
adipose tissues. The present GWAS results highlight UBE2E2 in association with the VAT/SAT 309 
ratio, a measure of the relative propensity to store fat in the visceral cavity rather than the 310 
subcutaneous compartment. We therefore speculate that SNP-associated modulation of gene 311 
expression or function of the protein products may impact adiposity through an effect on 312 
adipocyte differentiation and relative impairments in adipocyte development may partially 313 
explain a default propensity to deposit viscerally as compared to subcutaneously.  314 
Given the uniqueness of the ectopic fat traits, the sample size was limited in comparison 315 
to other meta-analyses.  Moreover, identification of candidate genes based on proximity to a 316 
GWAS signal may miss long distance interactions between genes and regulatory domains.  In 317 
contrast, multiethnic analyses, such as this study, not only enhance generalizability, but may 318 
also boost power for certain traits, particularly in contexts of limited allelic heterogeneity. The 319 
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possibility of false positive loci is also a consideration, given the absence of external replication.  320 
However, all newly identified loci passed FDR<1%.  Such statistical limitations are further 321 
mitigated in the case of ATXN1 and UBE2E2 by functional validation of these loci in murine 322 
adipose tissue.  323 
Combining large-scale discovery human genetics with the detailed fat phenotyping and 324 
experiments in model organisms identified 7 new loci in association with ectopic fat traits, of 325 
which ATXN1 and UBE2E2 demonstrated a functional effect during adipocyte differentiation.  326 
Future studies should further explore the exact mechanism by which modulation of ATXN1 and 327 
UBE2E2 impact adipocyte differentiation and whether this effect causally impacts systemic 328 
metabolic disease.  329 
 330 
331 
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FIGURE LEGEND 455 
 456 
Figure 1. Functional characterization of Atxn1, Ebf1, Rreb1 and Ube2e2.  457 
(a,b,e) Data is displayed as box/whisker plots where the center line represents the median, box 458 
limits contain the 25th-75th percentiles, and whiskers span max/min values.  459 
(a) Gene expression measured by qPCR in murine subcutaneous (SAT), perigonadal visceral 460 
(VAT), and pericardial (PAT) adipose tissues (n=6 mice). Statistical significance was assessed 461 
using ANOVA and Sidak’s correction for multiple comparisons. 462 
(b) Gene expression measured by qPCR in murine adipose tissues after 8 weeks of high fat 463 
feeding compared to normal chow fed controls (n=5 mice per group). Statistical significance was 464 
assigned using a two-sided T-test.  465 
(c) Gene expression measured by qPCR in cultured adipocyte progenitors isolated from the 466 
subcutaneous (SAT) or perigonadal visceral (VAT) depots (n=4 replicates). Cells were 467 
expanded to confluence and then collected at intervals after induction of adipogenic 468 
differentiation. Data displayed as mean, error bar=s.e.m. Statistical significance was assessed 469 
using ANOVA and Sidak’s correction for multiple comparisons to time 0. 470 
(d) Oil-red-o staining of progenitors isolated from subcutaneous adipose and exposed to 471 
retroviral delivery of shRNA constructs during ex vivo expansion and induction of adipogenesis. 472 
Relative to control vector carrying a scramble sequence, shRNA constructs specific for Atxn1 473 
and Ube2e2 impaired adipogenic differentiation. Scale=1mm. 474 
(e) Oil-red-o stain was alcohol extracted and quantified at OD520 (n=9 technical replicates). 475 
Statistical significance was assessed using ANOVA and Sidak’s correction for multiple 476 
comparisons to control (Scramble). Data representative of 3 independent experiments. 477 
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Table 1.  SNPs associated with ectopic fat traits (p<5x10-8)1. Association statistics were obtained using a sample-size weighted fixed-478 
effects meta-analysis implemented in METAL.18,19  479 
  Locus
2 Trait Strata Lead SNP Chr SNPID Position A13 A24 FreqA15 N 
Z 
score P-value
6 
Fat Volume Traits7,8 
NEW 
  ENSA PATadjHtWt ALL rs6587515 1 rs6587515 148875512 a g 0.09 11027 -5.94 2.8x10-9 
  GRAMD3 VATadjBMI WOMEN rs10060123 5 rs10060123 125711809 a c 0.23 9623 5.47 4.5x10-8 
  EBF1 
PATadjHtWt ALL rs1650505 5 rs1650505 157962312 a g 0.24 11566 -6.10 1.0x10-9 
  PAT ALL   5 rs2434264 157954781 t g 0.61 11614 5.93 3.0x10-9 
  RREB1 VATadjBMI ALL rs2842895 6 rs2842895 7051315 c g 0.50 17297 5.72 1.1x10-8 
  GSDMB SAT WOMEN rs2123685 17 rs2123685 35307415 t c 0.94 7137 5.52 3.4x10-8 
KNOWN 
  
TRIB2 
PATadjHtWt ALL 
rs10198628 2 rs10198628 12881948 a g 
0.42 11572 -8.88 6.7x10-19 
  PATadjHtWt MEN 0.43 5466 -6.68 2.4x10-11 
  PATadjHtWt WOMEN 0.42 6106 -6.02 1.8x10-9 
  PAT ALL 0.42 11605 -7.87 3.7x10-15 
  FTO SAT ALL rs7185735 16 rs7185735 52380152 a g 0.58 17812 -6.05 1.4x10-9 
Fat Attenuation Traits7,8 
NEW 
  ATXN1 SATHU MEN rs2237199 6 rs2237199 16538000 a g 0.11 5780 5.67 1.4x10-8 
Relative Fat Distribution Traits7,8 
NEW 
  UBE2E2 
VAT/SAT ratio ALL 
rs7374732 3 rs7374732 23178458 t c 
0.69 18205 -6.29 3.1x10-10 
  VAT/SAT ratio adjBMI ALL 0.69 18190 -5.64 1.7x10-8 
KNOWN 
  LYPLAL1 
VAT/SAT ratio ALL 
rs6689335 
1 rs6689335 217695305 t c 0.59 15214 -5.59 2.3x10-8 
  VAT/SAT ratio adjBMI ALL 1 rs6689335 217695305 t c 0.59 15199 -5.53 3.2x10-8 
  LY86 
VAT/SAT ratio ALL 
rs912056 6 rs912056 6681196 a t 
0.35 17387 -5.96 2.5x10-9 
  VAT/SAT ratio adjBMI ALL 0.35 17372 -5.98 2.3x10-9 
1 SNPs are grouped by ectopic fat trait and are listed by new discoveries and then previously identified loci.  Any association attaining 480 
genome-wide significance (p<5x10-8) is listed. 481 
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2 Conventional locus name based on closest gene in the region 482 
3 A1 is the coded allele 483 
4 A2 is the non-coded allele 484 
5 FreqA1 is the allele frequency of Allele1 485 
6 P-values are double genomic control corrected 486 
7 European and African ancestry cohorts contributed to all ectopic fat traits; Chinese and Hispanic ancestry cohorts contributed only 487 
to pericardial volume traits 488 
8 Abbrevations: 489 
SAT - Subcutaneous Adipose Tissue Volume 490 
VAT - Visceral Adipose Tissue Volume 491 
PAT - Pericardial Adipose Tissue Volume 492 
SATHU - Subcutaneous Adipose Tissue Attenuation 493 
VATHU - Visceral Adipose Tissue Attenuation 494 
VAT/SAT ratio - Visceral to Subcutaneous Adipose Tissue Volume Ratio 495 
adjBMI - Model Adjusted for BMI 496 
adjHtWt - Model Adjusted for Height and Weight497 
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Figure 1.  498 
499 
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Online Methods 500 
Study Participants 501 
Up to 18,332 participants from 13 cohorts of European and African ancestry were 502 
available for analysis of subcutaneous and visceral adipose tissue volumetric traits, up to 503 
11,596 from 6 cohorts of European, African, Asian, and Hispanic ancestry were available for 504 
analysis of pericardial adipose volumetric traits, up to 12,519 participants from 5 cohorts of 505 
European and African ancestry were available for analysis of attenuation traits, and up to 506 
18,191 participants from 6 cohorts of European and African ancestry were available for analysis 507 
of relative fat distribution traits.  This epidemiological sample constitutes the largest known 508 
collection of participants with radiologically derived ectopic fat measures and genetic data at the 509 
inception of this project.  Supplementary Table 2 and 3 contain information regarding imaging 510 
modality used by each cohort, distribution by sex and ancestry per cohort for each trait analyzed 511 
and cohort descriptive information. All participants provided informed consent and each study 512 
was approved by their governing ethics committee.   513 
 514 
Trait assessment 515 
 The traits measured in this study can be categorized into three groups: 1) fat volume 516 
measurements: subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and 517 
pericardial adipose tissue (PAT); 2) fat attenuation measurements: subcutaneous adipose 518 
tissue attenuation (SATHU) and visceral adipose tissue attenuation (VATHU); and 3) relative fat 519 
distribution measurements: visceral-to-subcutaneous adipose tissue volume ratio (VAT/SAT 520 
ratio).  All volume-based measures were assessed by computed tomography (CT) or magnetic 521 
resonance imaging (MRI) following study-specific protocols; attenuation-based measures were 522 
assessed by CT following study specific protocols.  Please see Supplementary Table 2 and 523 
Supplementary Note for further detail. 524 
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The following traits were created by each cohort in the overall sample, women and men: 525 
volume-based traits - SAT, VAT, VAT adjusted for BMI, PAT, PAT adjusted for height and 526 
weight; attenuation-based traits - SATHU and VATHU; relative-distribution traits - VAT/SAT 527 
ratio, VAT/SAT ratio adjusted for BMI pericardial traits.  The rationale for including the ectopic 528 
fat traits, the adjustment models, and the sex-stratified analyses was 4-fold.  First, ectopic fat 529 
measures are correlated with each other and with general adiposity and we wished to adjust for 530 
these factors as potential confounders or intermediates and to examine the genetic associations 531 
independent of the adjustment factor. Please see refer to Supplementary Table 7 for pairwise 532 
correlations of all traits within FHS, the largest participating cohort. For example, the correlation 533 
between VAT and BMI is 0.71 to 0.75 and adjusting for BMI when examining VAT provides the 534 
relative amount of VAT controlling for degree of general adiposity.  Although the correlations 535 
between VAT/SAT ratio and BMI are modest, adjusting for BMI allowed us to examine the 536 
propensity to store fat viscerally compared to subcutaneously independent of general adiposity.  537 
Second, adjustment of covariates reduces the residual variance of the trait associated with the 538 
given covariate and thus increases power to detect genetic associations.  Third, in the adiposity 539 
genetics literature there is evidence of sexually dimorphic loci in which the variance explained is 540 
larger in women versus men28 and association of the loci is markedly stronger in women 541 
compared to men, and vice versa.14,22 Lastly, we adjusted PAT for height and weight to be 542 
consistent with our prior work13 (see Supplementary Table 1 for guide to nomenclature for traits 543 
and adjustment models).   544 
Due to the known differences in body fat distribution by sex, each cohort created sex- 545 
and ancestry-specific residuals adjusted for age, age-squared, smoking status, measures of 546 
subpopulation stratification and family structure (if necessary).  Family-based studies created an 547 
additional set of residuals from all participants (both women and men) to account for family 548 
structure when analyzing the overall sample.  Participants with missing genotype, phenotype or 549 
covariate data were excluded from analysis as pre-specified in the analysis plan. 550 
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Study Specific Protocol 551 
 Trait measurements and descriptions from each cohort are available in Supplementary 552 
Material under “Cohort Specific Information and Protocols”.   553 
 554 
Genotyping and Imputation 555 
 Each cohort was genotyped as specified in Supplementary Table 4 and performed 556 
ancestry-specific imputation up to ~2.6 million SNPs based on the HapMap Project Phase 2 557 
haplotypes (http://hapmap.ncbi.nlm.nih.gov/index.html.en).  All newly identified loci were 558 
imputed with imputation qualities >0.8 in each cohort.  Imputation quality by locus and cohort 559 
are available in Supplementary Table 8.   560 
 561 
Heritability Analysis 562 
Heritability was estimated from the Framingham Heart Study using variance components 563 
analysis in SOLAR.16   564 
 565 
Genetic Correlation Analysis 566 
Pairwise genetic correlations between subcutaneous fat (volume and attenuation), 567 
visceral fat (volume and attenuation), ratio of visceral-to-subcutaneous fat and BMI were 568 
calculated using SOLAR16 in the Framingham Heart Study among 3,312 participants. We used 569 
residuals adjusted for age and sex. Two separate hypotheses were tested: 1) RhoG = 0 is the 570 
test for overlapping genetic correlations, and 2) absolute value (RhoG) = 1 is the test for non-571 
overlapping genetic correlations. 572 
 573 
Statistical Analysis 574 
Within each cohort, by ancestry and by sex, genome-wide linear regression analyses 575 
were conducted on the 11 trait and model combinations assuming an additive genetic model 576 
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using allele dosages.  All traits approximated a normal distribution and untransformed traits 577 
were used for analysis.  To prevent the undue influence of rare variants and/or of poorly 578 
imputed SNPs, we included variants with a minor allele count >10 and imputation quality >0.4 579 
(for MaCH29) or >0.3 (for IMPUTE30) in each cohort. 580 
For multiethnic analysis, we combined all cohort-specific results using a sample size-581 
weighted fixed-effects meta-analysis (Stouffer’s method) as implemented in METAL18,19 to allow 582 
for differences in trait measurement and scaling due to different imaging modalities across 583 
cohorts. European and African ancestry cohorts contributed to all ectopic fat traits; Chinese and 584 
Hispanic ancestry cohorts contributed only to pericardial volume traits (Supplementary Table 3).  585 
All analyses were performed for the overall sample (ALL), among women only (WOMEN) and 586 
among men only (MEN).  All analyses were corrected for genomic control at the cohort-level.  587 
We excluded variants with minor allele frequency (MAF)<5% due to the low power to detect 588 
associations of such variants. We set a traditional genome-wide significance threshold at 589 
P<5x10-8, the Bonferroni correction for the number of independent and common variants across 590 
the genome (~1 million SNPs). All p-values represent two-sided p-values unless otherwise 591 
specified.  All regional association plots, Manhattan plots, and QQ plots were created using R 592 
version 3.1.1 (https://cran.r-project.org/).  Linkage disequilibrium plots were created using 593 
SNAP31 and the gap R package (https://www.jstatsoft.org/article/view/v023i08). 594 
To correct for multiple testing, false discovery rate (FDR) was calculated across the 27 595 
ectopic fat GWAS scans using the qvalue R package (http://github.com/jdstorey/qvalue). 596 
FDR<1% was set as the multiple testing corrected significance threshold.  597 
For mouse studies, individual cages of mice were randomly assigned in an un-blinded 598 
fashion to normal chow or high fat diet. Each in vivo study was conducted one time and no mice 599 
were excluded from the analyses. In the absence of a priori data regarding the variance of gene 600 
expression in the tissues of interest, we applied sample sizes that have in our experience been 601 
of sufficient size to detect a two-fold increase in gene expression.  For normally distributed data 602 
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from more than two groups (Shapiro-Wilk), an ANOVA test followed by Sidak’s correction for 603 
multiple testing was conducted (Figures 1a,c,e). For non-normal data a Kruskal-Wallis test was 604 
used. For comparisons between two normally distributed groups (Figure 1b: chow versus high 605 
fat) a two-sided T-test was used, unless the data was non-normal, in which case a Mann-606 
Whitney test was used. Data were expressed as mean, s.e.m. Significance was assigned for 607 
two-sided p<0.05. Data were analyzed and graphed using JMP 10.0 (SAS institute) and Prism 6 608 
(Graphpad). 609 
 610 
Sensitivity Analyses 611 
 To ensure the newly identified loci from our multiethnic analysis were robust and not 612 
driven by statistical outliers related to ancestry, ancestry-specific meta-analysis results were 613 
compared with each other with respect to the minor allele, the minor allele frequency and 614 
direction of the Z-score association statistic (Supplementary Table 9).  Due to the scaling 615 
differences in imaging modalities across each cohort and use of the sample size weighted meta-616 
analysis heterogeneity statistics cannot be calculated.   617 
The lead SNP for the GSDMB locus associated with SAT in women was not observed in 618 
non-European ancestry cohorts and thus was not included in this analysis.  For each of the 619 
remaining 6 lead SNPs from the newly identified ectopic fat loci, Z scores were directionally 620 
consistent across ancestry-specific meta-analyses (please see Supplementary Figure 2 for 621 
forest plots of each locus and Supplementary Figure 3 for linkage disequilibrium [LD] plots 622 
across ancestry).  For 5 of these loci, the minor allele was identical across ancestries; only the 623 
minor allele of rs2842895 (RREB1) differed between the European ancestry and African 624 
ancestry cohorts.  This observation may explain the slight attenuation in the association of 625 
RREB1 and VATadjBMI after combining European and African ancestries in the multiethnic 626 
meta-analysis (PEuropean-ancestry=5.8x10-9 to Pmultiethnic=1.1x10-8), although the multiethnic result 627 
remains genome-wide significant. 628 
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Analyses of Related Traits 629 
 For each SNP attaining genome-wide significance in association with any ectopic fat 630 
trait, we extracted association results in each strata of analysis (ALL, WOMEN, and MEN) for 631 
related ectopic fat traits within our study.   632 
To investigate the association of the new ectopic fat loci with measures of generalized 633 
adiposity (BMI) and central obesity (WHR) - two traits that are strongly correlated with, but 634 
distinct from ectopic fat - we evaluated the lead genome-wide significant SNPs in publically 635 
available datasets from the most recent GIANT meta-analyses of BMI and WHR.14,15  636 
 To investigate associations of new loci with cardio-metabolic traits that are 637 
epidemiologically associated with ectopic fat, cross-trait evaluations for the lead SNPs only were 638 
performed in the publically available datasets from the MAGIC (Meta-Analyses of Glucose and 639 
Insulin Consortium for fasting glucose and insulin32), GLGC (Global Lipids Genetics Consortium 640 
for high-density lipoprotein cholesterol, triglycerides and total cholesterol33), 641 
CARDIoGRAM+CAD consortium (Coronary ARtery DIsease Genome wide Replication and 642 
Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics for coronary 643 
artery disease and myocardial infarction34,35), ICBP (International Consortium for Blood 644 
Pressure for systolic and diastolic blood pressure36), and DIAGRAM (DIAbetes Genetics 645 
Replication And Meta-analysis25).  646 
 647 
Analysis of general adiposity and central adiposity loci 648 
To evaluate the relationship between the known 97 BMI and 49 WHR loci14,15 with 649 
ectopic fat traits, we examined the association for these loci with fat volume and relative fat 650 
volume traits among the combined multiethnic sample of women and men. Because the ectopic 651 
fat data may be underpowered to determine statistically significant results, we hypothesized that 652 
the direction of the BMI and WHR findings would be directionally consistent with the ectopic fat 653 
traits, even if the p-values were not significant. Binominal tests were used to test the 654 
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significance of direction consistent associations (1-sided p-values).  If the binominal test across 655 
the BMI or WHR loci was significant, a second 1-sided binominal test was performed evaluating 656 
consistency of associations restricting to SNPs with nominally significant associations (P<0.05).    657 
 658 
Functional Profiling - Bioinformatics and Annotation 659 
To further characterize novel genome-wide significant loci, the following bioinformatics 660 
databases were queried for the lead ectopic fat loci: GWAS Catalog 661 
(https://www.ebi.ac.uk/gwas/; access date: 10/15/2015) to investigate other traits associated 662 
with newly identified loci, and HaploReg23 and RegulomeDB24 to identify regulatory elements 663 
overlapping the loci for the index SNP and SNPs in LD with the index SNP (r2>0.8; 664 
Supplementary Table 13).  To contextualize the newly identified ectopic loci and the surrounding 665 
genes, SNIPPER (https://github.com/welchr/Snipper.git) was used to search for biologically 666 
relevant mechanisms (Supplementary Table 14).  667 
 668 
Variance Explained 669 
 The variance explained for each of the loci was approximated using the following 670 
formula R2=β2var(SNP)/var(ectopic fat trait), where β2 is the estimated effect of the SNP on the 671 
ectopic fat trait, and var(SNP)=2*MAFSNP*(1-MAFSNP).  Because sample-size weighted fixed-672 
effect meta-analysis does not estimate effect sizes, the beta-coefficient for the association 673 
between the SNP and ectopic fat trait and the variance of the ectopic fat trait were obtained 674 
from cohort level analysis per contributing study.  The mean of the variance explained per locus 675 
across all contributing cohorts ranges from 0.1% to 4.4% (Supplementary Table 15). 676 
 677 
 678 
 679 
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Power Calculations 680 
 Power for discovery in the ectopic fat genomewide scan was calculated using 681 
GWAPower37 using the range of sample size in this study (5,842-18,332 participants) and 682 
setting α=5x10-8.  For the smallest sample size analyzed (N=5,842) we had ≥80% power to 683 
detect loci explaining at least 0.64% of the trait variance.  For the largest sample size analyzed 684 
(N=18,332), we had ≥80% power to detect loci explaining at least 0.20% of the trait variance.  685 
For example, our novel loci explained from 0.15-4.4% of the trait variance for ectopic fat as seen 686 
in Supplementary Table 15.  687 
 To address the power to detect associations for the lookup analyses, we used 688 
GWAPower37 with the maximum sample sizes from the each of the quantitative trait datasets 689 
(52,000-94,000 participants), a modest range of variance explained (0.01-0.05%; based on the 690 
variance explained for each locus [0.1-4.4%] and the age- adjusted correlations between 691 
ectopic fat and the cardiometabolic trait of interest [R2=0.02-0.46]) and a Bonferroni corrected α692 
=7.4x10-4 (~0.05/66 pairs of SNP-trait associations). For the smallest dataset (Fasting Insulin, 693 
N~52,000), we had 80% power to detect loci explaining at least 0.030% of the variance in 694 
fasting insulin.  For the largest dataset (HDL-C and total cholesterol, N~94,000), we had 80% 695 
power to detect loci explaining 0.018% of the variance in HDL-C or total cholesterol.  These 696 
calculations indicate that we largely had adequate power for a large portion of the SNP-trait 697 
associations.  698 
 699 
eQTL analysis 700 
Using a curated collection of 6 eQTL datasets in adipose-related tissues, index SNPs at 701 
newly identified ectopic fat loci were examined in association with transcript expression. 702 
Datasets were collected through publications, publically available sources, or private 703 
collaboration.  The eQTL datasets met criteria for statistical thresholds for SNP-gene transcript 704 
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associations as described in the original papers and were limited to index SNPs and SNPs in 705 
LD with the index SNP (r2>0.8) across all ancestries available in the 1000 Genomes Project pilot 706 
(SNAP31).  A general overview of the larger collection of more than 50 eQTL studies from which 707 
the adipose-related datasets (omental, visceral and subcutaneous adipose,38-42) were derived 708 
from has been published.43  Additional eQTL data was integrated from online sources including 709 
ScanDB, the Broad Institute GTEx Portal, and the Pritchard Lab (eqtl.uchicago.edu). Results for 710 
GTEx Analysis V4 for subcutaneous adipose tissue were downloaded from the GTEx Portal and 711 
then additionally filtered as described below (www.gtexportal.org41). Splicing QTL (sQTL) results 712 
generated with sQTLseeker with false discovery rate P≤0.05 were retained. For all gene-level 713 
eQTLs, if at least 1 SNP passed the tissue-specific empirical threshold in GTEx, the best SNP 714 
for that eQTL was always retained. All gene-level eQTL SNPs with P<1.67x10-11 were also 715 
retained, reflecting a global threshold correction of P=0.05/(30,000 genes X 1,000,000 tests). 716 
Cis-eQTL analysis showed SNPs at ENSA (a locus identified in association with PAT) 717 
was correlated with multiple transcripts (MRPS21, CTSK and LASS2, P<10-4) in subcutaneous 718 
and omental adipose tissue (Supplementary Table 16), suggesting these may be the relevant 719 
transcripts at this locus and not ENSA, the closest gene to the lead association signal.  720 
However, the ENSA locus was not selected for functional validation, as there were too many 721 
genes in the region to practically follow up.  No other eQTLs were identified. 722 
 723 
Characterization in Model Organisms 724 
Selection of Loci for Characterization 725 
 For functional follow-up and characterization of ectopic fat loci, four gene-trait 726 
associations were selected based on visual examination of regional association plots 727 
(Supplementary Figures 1a-g) for a localized association within a gene body at each locus 728 
(RREB1, ATXN1 and UBE2E2) or localized association near the gene body and the lack of 729 
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other genes within 1Mbp of the lead SNP (EBF1) to increase the probability of experimentally 730 
testing the likely causal gene in murine models.   731 
 732 
Mouse studies 733 
  Experiments were approved by and in compliance with the ethical regulations of the 734 
Harvard Medical Area Standing Committee on Animals. Male C57BL/6 mice were purchased 735 
from Charles River and housed at 22 ± 2°C, with a 12h light (0700-1900 h), 12h dark (1900-736 
0700 h) cycle and ad libitum access to food and water. With the exception of the data shown in 737 
Supplementary Figure 6, experiments were conducted in male mice.  Diet-induced obesity was 738 
modeled with high fat (D12492) and control chow (D12450J) matched for sucrose content 739 
(Research Diets, Inc.). Adipose tissue was harvested, homogenized in Trizol (Life 740 
Technologies), and RNA extracted according to the manufacturers protocol.  cDNA was 741 
synthesized using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies).  742 
qPCR was performed using iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA) on 743 
an iCycler (Bio-Rad) instrument. See Supplementary Table 17 for primer sequences used in 744 
these analyses. Gene expression was normalized to 18S. The delta-delta CT method was 745 
utilized to calculate fold change in transcript levels.   746 
 747 
Comparison of baseline adipose-specific expression of Atxn1   748 
Given that the SNP-ectopic fat association for ATXN1 was confined to men, we 749 
assessed gender-specific effects in mice of Atxn1 expression.   There was no detectable gender 750 
effect on the baseline, adipose-specific expression of Atxn1 (Supplementary Figure 6).   751 
 752 
Adipogenesis assay 753 
Adipose tissue from C57BL/6 mice was minced and digested with collagenase D 754 
(Roche) in a shaking water bath (37C, 225rpm, 40min). The digest was centrifuged at 400g for 755 
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10 min. Pelleted stromal vascular cells were filtered (40µm) and then washed with PBS and 756 
subjected to additional negative selection (CD31- / lineage-) adapted from previously performed 757 
methods44 using antibody coated microbeads (Miltenyi Biotec). Cells were cultured to 758 
confluence in collagen-coated plates and stimulated with dexamethasone, insulin and 3-759 
isobutyl-1-methylxanthine to induce adipogenic differentiation. For genetic loss of function 760 
assays, validated shRNA sequences (Broad, Ube2e2: TRCN0000040962; Atxn1: 761 
TRCN0000240655) or scramble sequence were subcloned into a retroviral vector (pMKO.1). 762 
Gene knock-down efficiency was confirmed by qPCR in 3T3L1 cells, in each instance 763 
reproducibly achieving a minimum of 60% reduction of transcriptional activity. Differentiation into 764 
mature lipid-containing adipocytes was determined by oil-red-o (ORO) staining and quantified 765 
by measuring alcohol-extracted ORO dye at optical density 520 nm (OD520).  766 
 767 
Cohort Specific Acknowledgements and Funding  768 
 Please see the Supplementary Note for acknowledgements and funding statements from 769 
all participating cohorts. 770 
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